Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor.
about
The RNA polymerase II C-terminal domain promotes splicing activation through recruitment of a U2AF65-Prp19 complexThe U2AF35-related protein Urp contacts the 3' splice site to promote U12-type intron splicing and the second step of U2-type intron splicingDistinct activities of the DExD/H-box splicing factor hUAP56 facilitate stepwise assembly of the spliceosomeSRp30c is a repressor of 3' splice site utilization.Sorting out the complexity of SR protein functionsThe role of U2AF35 and U2AF65 in enhancer-dependent splicingDifferential 3' splice site recognition of SMN1 and SMN2 transcripts by U2AF and U2 snRNPThe SRm160/300 splicing coactivator is required for exon-enhancer functionRole for Fox-1/Fox-2 in mediating the neuronal pathway of calcitonin/calcitonin gene-related peptide alternative RNA processingAssembly of splicing complexes on exon 11 of the human insulin receptor gene does not correlate with splicing efficiency in-vitroDistribution of SR protein exonic splicing enhancer motifs in human protein-coding genes.Biased exon/intron distribution of cryptic and de novo 3' splice sitesThe RNA Splicing Response to DNA DamageIrf3 polymorphism alters induction of interferon beta in response to Listeria monocytogenes infectionAlternative splicing of intron 3 of the serine/arginine-rich protein 9G8 gene. Identification of flanking exonic splicing enhancers and involvement of 9G8 as a trans-acting factorRESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exonsProteasome-mediated proteolysis of SRSF5 splicing factor intriguingly co-occurs with SRSF5 mRNA upregulation during late erythroid differentiationCooperative actions of Tra2alpha with 9G8 and SRp30c in the RNA splicing of the gonadotropin-releasing hormone gene transcriptArginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279KFunctional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.Human genomic sequences that inhibit splicing.An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers.Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing.An exonic splicing silencer in the testes-specific DNA ligase III beta exonExonic splicing enhancers in fission yeast: functional conservation demonstrates an early evolutionary origin.Genomic features defining exonic variants that modulate splicing.A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.Exonic splicing enhancer motif recognized by human SC35 under splicing conditionsMultiple splicing defects in an intronic false exon.A single polypyrimidine tract binding protein (PTB) binding site mediates splicing inhibition at mouse IgM exons M1 and M2.Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switchRegulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expressionMultiple tandem splicing silencer elements suppress aberrant splicing within the long exon 26 of the human Apolipoprotein B gene.Caspase-2 pre-mRNA alternative splicing: Identification of an intronic element containing a decoy 3' acceptor site.Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M.The polypyrimidine tract binding protein (PTB) represses splicing of exon 6B from the beta-tropomyosin pre-mRNA by directly interfering with the binding of the U2AF65 subunitDirect repression of splicing by transformer-2.Pre-mRNA splicing in the absence of an SR protein RS domain.Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing.Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer.
P2860
Q24301107-976B71DD-841F-4591-95B3-8D79CF19D449Q24305157-B42FAC06-C2EA-444C-8744-151C6FDE2C2AQ24309076-E2A1DD1B-9656-42E5-9FAF-A55FB18393B2Q24537431-0DD97EC2-6FE9-41B7-BAAA-E5136198BB80Q24539813-5F94C20B-2BAE-41CD-A9CB-23CCF18652E1Q24540026-EF514577-9B11-44CE-8127-CC4D50625436Q24651863-1D4ACB72-D394-4866-AE46-2F7665036866Q24658182-4DE3A223-F031-4DFF-87C8-56EE5FECBE97Q24674098-1CA28576-5997-4038-B8A1-A9D33311EB89Q24793697-FB679F41-B5E8-4E8C-A11E-52383F2A8FDDQ24812666-C5336BC8-0D8B-4EEA-9C6C-E7B6095B28E7Q24817064-4B00E5AB-5629-447B-8C33-FEE56136ACD3Q26777046-E37D3E0E-EC28-49A4-BF90-7F87762A27D2Q27314886-EF739647-5C5C-4D25-8D41-74901104B74CQ28138789-E03C9975-9054-47A8-8A4C-BF1A671855ECQ28268426-018393BA-CD8B-41A0-9EC0-1566300DAFEAQ28487906-5F04A4B4-B817-44D1-9BB7-6E4F1A34EDF4Q28509733-73C934F8-7270-45BF-8ECB-51054D252F2EQ28573100-C888D10B-D5E6-48E2-A370-BB125B4B5D87Q30437897-462D3BAF-7041-406F-B58F-3B4156CC11F9Q30910840-DC6C2004-7C8F-4DFB-8735-5557C2FEDA69Q33249150-A46E249D-05E5-42A0-98E2-209550D9840AQ33297016-96F9421F-9F46-4AAB-A182-41008D2D7C41Q33612479-96CE1FA6-D457-41F7-BB03-5CC4548FC60AQ33763755-F5A9391D-BB5F-4E21-A66E-BAC714A7345AQ33861632-08BCAEAC-B6E5-44E9-B0F7-4D493A3BD496Q33954292-952E9B45-1D0B-4F2D-BDA8-33BF836F85F9Q33961789-EFF9D391-F99B-46ED-9979-8EAA69301165Q33965191-ABB0D942-2540-4F23-8CC0-9D5110C872BBQ34365702-299F5ADE-628C-46FF-A30A-C4D10A581F33Q34370629-33BA7004-FA50-4F9F-8196-5D79274399CEQ34546893-EC65766C-05D2-48F9-8246-BC67396477C7Q34580416-8F5F5649-E61F-41BA-BFAE-457F952B4470Q34633549-F7950491-42A2-4EBC-9E11-A4CDECFF361EQ34963359-1D2AD45A-6EA6-46C4-BAC8-05578B50C38AQ35131606-004BD854-6DB3-4A70-BF4F-52BD8793F3AAQ35161859-4B158EEA-35B1-428E-A0B1-AAFCBB57CA01Q35209029-2E3FC305-2152-4316-81A8-CFF89277DAD0Q35628253-7DE5A0A1-A50B-4537-BEEA-1D8A95FAD215Q35677811-288FE730-BFFD-4451-B4C9-CC521EFA75E1
P2860
Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pre-mRNA splicing of IgM exons ...... licing enhancer and inhibitor.
@ast
Pre-mRNA splicing of IgM exons ...... licing enhancer and inhibitor.
@en
type
label
Pre-mRNA splicing of IgM exons ...... licing enhancer and inhibitor.
@ast
Pre-mRNA splicing of IgM exons ...... licing enhancer and inhibitor.
@en
prefLabel
Pre-mRNA splicing of IgM exons ...... licing enhancer and inhibitor.
@ast
Pre-mRNA splicing of IgM exons ...... licing enhancer and inhibitor.
@en
P2860
P356
P1433
P1476
Pre-mRNA splicing of IgM exons ...... licing enhancer and inhibitor.
@en
P2093
P2860
P304
P356
10.1101/GAD.13.4.462
P577
1999-02-01T00:00:00Z